Rhinitis, Allergic, Seasonal: all 396 studies

Page 2 of 4. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.

• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)CompletedNCT00732381Phase 3Results posted
• Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)CompletedNCT00728416Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal AllergiesCompletedNCT00720278Phase 3Results posted
• A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00719862Phase 3Results posted
• Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis TrialCompletedNCT00691665Phase 4Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660829Phase 3Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00660517Phase 3Results posted
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00653224Phase 4Results posted
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal AllergiesCompletedNCT00651118Phase 3Results posted
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00621959Phase 4Results posted
• Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen ExtractCompletedNCT00619827Phase 1Results posted
• Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?CompletedNCT00618332Not applicableResults posted
• Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old PatientsCompletedNCT00578929Phase 3Results posted
• Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)CompletedNCT00552110Phase 2Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00502775Phase 4Results posted
• This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)CompletedNCT00491504Phase 4Results posted
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)CompletedNCT00468312Phase 3Results posted
• A 5-way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With RhinitisCompletedNCT00464568Phase 2Results posted
• Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)CompletedNCT00453063Phase 3Results posted
• Fluticasone Furoate Nasal Spray Versus Oral FexofenadineCompletedNCT00435461Phase 4Results posted
• Study for the Treatment of Intermittent Allergic Rhinitis With Desloratadine (Study P04683)CompletedNCT00406783Phase 3Results posted
• Treatment of Olfactory Dysfunction in Seasonal Allergic RhinitisTerminatedNCT00361439Phase 4Results posted
• Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)CompletedNCT00358527Phase 4Results posted
• Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive SubjectsCompletedNCT00295022Phase 4Results posted
• A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00291642Phase 2Results posted
• The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR)(P04579)CompletedNCT00276016Phase 3Results posted
• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)CompletedNCT00070707Phase 4Results posted
• A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisActive, not recruitingNCT07688772Phase 3
• Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic RhinitisActive, not recruitingNCT07291284Phase 3
• A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis.CompletedNCT07155499Phase 1/2
• A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT07091357Phase 2
• Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT07052097Phase 2
• Phleum Pratense and Dactylis Glomerata Allergen Extracts StandardizationCompletedNCT06957496Not applicable
• Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in AdultsCompletedNCT06861101Phase 2
• A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic RhinitisCompletedNCT06837233Phase 2
• Evaluation of an Adjusted Cutoff Value for S.P.A.T (Skin Prick Automated Test) Device in Allergic SubjectsCompletedNCT06803953Not applicable
• Breathe-Easy: Hayfever Care for Patients With Seasonal Allergic RhinitisCompletedNCT06765239Not applicable
• Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic RhinitisCompletedNCT06760182Phase 2
• A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic RhinitisCompletedNCT06200766Phase 3
• Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)Active, not recruitingNCT06189742Phase 2
• Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal SprayCompletedNCT06180083Phase 1
• Azelastine Allergen Chamber - Onset of Action StudyCompletedNCT06126952Phase 2
• Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch PollenCompletedNCT06085963Not applicable
• Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis AdultCompletedNCT06046391Phase 2
• Study to Evaluate Safety, Tolerability and Explorative Efficacy of DM-101PX in Birch Pollen Allergic ParticipantsCompletedNCT06037148Phase 1
• Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control StudyCompletedNCT05960266Early Phase 1
• Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic RhinitisTerminatedNCT05887843Phase 1
• Validation and Reproducibility of S.P.A.T. With AllergensCompletedNCT05824637Not applicable
• Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.CompletedNCT05590598Phase 3
• A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After TreatmentCompletedNCT05560698Not applicable
• Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.CompletedNCT05533385Not applicable
• A Study of CM310 in Patients With Uncontrolled Seasonal Allergic RhinitisCompletedNCT05470647Phase 2
• Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic RhinitisCompletedNCT05346718Not applicable
• Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic RhinitisCompletedNCT05311475Phase 3
• Mometasone Furoate Nasal Spray in Italian ChildrenCompletedNCT05301647
• Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen ExtractCompletedNCT05297760Phase 1/2
• Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic RhinitisCompletedNCT05234580Phase 2
• Tyrosine Allergoid Paediatric and Adult StudyActive, not recruitingNCT05186025
• Allergen Challenge Trial of IRL201104 in Seasonal Allergic RhinitisCompletedNCT05098522Phase 2
• Interaction Between Air Pollution, Pollens and Allergic RhinitisCompletedNCT05007327
• S.C. Immunotherapy With BM41 in Patients With Allergic Rhino-conjunctivitis Caused by Birch PollenCompletedNCT04912076Phase 1
• Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/RhinoconjunctivitisTerminatedNCT04874714Phase 3
• To Investigate Drug-drug Interaction and Relative Bioavailability Between the FDC AzelastineHCL/Beclomethasone Dipropionate Nasal Spray, & Beclomethasone Dipropionate Nasal Spray in the Test Vehicle, and RinoClenil® Nasal SprayCompletedNCT04817800Phase 1/2
• Effectiveness of Sodium Hyaluronate In Relieving Nasal Symptoms Of Children With Seasonal Allergic RhinitisStatus unknownNCT04752956Not applicable
• Psychological Factors That Influence Severity of Allergic RhinitisCompletedNCT04709614
• Biomarkers in Nasal Samples of Seasonal Allergic RhiniticsCompletedNCT04670627
• Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥ 12 Years and < 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional TherapiesCompletedNCT04648930
• Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.CompletedNCT04622917Phase 4
• Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure ChamberCompletedNCT04583202Not applicable
• The Efficacy of Preseasonal Omalizumab TreatmentCompletedNCT04489121Not applicable
• Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority AllergensCompletedNCT04435678Not applicable
• Audio Data Collection for Identification and Classification of CoughingCompletedNCT04326309
• Efficacy, Safety and Underlying Mechanisms of Sphenopalatine Ganglion Acupuncture for Seasonal Allergic RhinitisStatus unknownNCT04052945Not applicable
• Study to Assess the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of a Single Dose of REGN5713-5714-5715 in Healthy Adult ParticipantsCompletedNCT03969849Phase 1
• A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPLCompletedNCT03931993Phase 1
• Iron and Pollen Allergy in WomenCompletedNCT03816800Not applicable
• Effect of the Nasal Gel "Nascum®-Plus" on Allergic SymptomsCompletedNCT03772405Not applicable
• Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal SprayCompletedNCT03755557Phase 3
• Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic RhinoconjunctivitisStatus unknownNCT03724240Phase 3
• Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of PollutantsCompletedNCT03664882Phase 3
• Effect and Underlying Immunological Mechanisms of Sublingual Immunotherapy in Allergic RhinitisCompletedNCT03649139Phase 3
• Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy In Southern Europe.CompletedNCT03636919
• A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis PatientsCompletedNCT03570957Phase 1
• Microassay and Allergy Skin Prick Test Correlation StudyStatus unknownNCT03514303
• Evaluation of Nasal Inflammatory BiomarkersCompletedNCT03450031Not applicable
• Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)CompletedNCT03444506Phase 2
• Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic DermatitisCompletedNCT03315611Not applicable
• Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric AgeCompletedNCT03286049
• The Effects of Sphenopalatine Ganglion Acupuncture in Patients With Seasonal Allergic RhinitisCompletedNCT03282630Not applicable
• Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy TreatmentCompletedNCT03097432
• Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei HeuschnupfenCompletedNCT03014661
• MP-AzeFlu Allergen Chamber - Onset of Action StudyCompletedNCT03004131Phase 4
• Intralymphatic Immunotherapy in Increasing Doses, SubstudyCompletedNCT02975479Phase 2/3
• Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)CompletedNCT02932774Phase 4
• Effectiveness of Bifidobacteria in Children Affected by Seasonal Allergic RhinitisStatus unknownNCT02807064Phase 3
• Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen AllergyCompletedNCT02654223Phase 2
• Evaluation of High Speed Laser Doppler Imaging TechnologyCompletedNCT02619331Not applicable
• Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™CompletedNCT02582073Phase 2
• Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic RhinoconjunctivitisCompletedNCT02560948Phase 3
• 4"S" - Seasonal Symptoms Suppression StudyStatus unknownNCT02557269Phase 4

← Rhinitis, Allergic, Seasonal overview